Buprenorphine prescription by general practitioners in a French region.
about
Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.Polydrug abuse: a review of opioid and benzodiazepine combination useNaloxone treatment in opioid addiction: the risks and benefits.Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans.Indicators of buprenorphine and methadone use and abuse: what do we know?Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002.The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural OntarioPreference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment.Abuse of buprenorphine by intravenous injection--the french connection.Buprenorphine for heroin addicts: the issue of illicit opioid abuse during maintenance.Subjective effects of the nicotine lozenge: assessment of abuse liability.Epidemiological characterization of drug overconsumption: the example of antidepressants.Use of slow-release oral morphine for the treatment of opioid dependence.Short-term buprenorphine maintenance: treatment outcome.Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network.French general practitioners' attitudes and prescription patterns toward buprenorphine maintenance treatment: does doctor shopping reflect buprenorphine misuse?Induction of patients with moderately severe methadone dependence onto buprenorphine.Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey.
P2860
Q30950812-3BBCFE13-75F7-4CE1-BF59-2A928D9850E6Q34253036-A1B2DEB9-EF1D-407A-BD94-CC0BFAC89A40Q36266246-1BB5D22B-11CF-4882-A340-14570C0F8FB6Q36762428-09442CD2-4E5A-466F-A19B-DEB0D3D2A69EQ36874673-F9123FB8-8384-4038-A983-4FC343EB6FA1Q37045326-3AC4A998-8AE2-42CE-90D2-F0FC33C5D77CQ37405474-58DB3DCD-DD18-458C-A3DD-0245BF533F37Q37607792-9FFD785C-220D-49CE-8040-744E807EEFF9Q40991270-BE1BEDB8-60D5-4E0C-BFEF-011AF524B5DAQ44163657-96BE434B-2884-4451-B133-AC8BE5A6D935Q44332572-3842AFC0-71C8-47D9-AA3F-DC518D3B51C7Q44343037-27E036C0-7CFE-4616-BAD8-CF44A195B5DFQ44344350-EC539C27-781A-493B-837C-B0F596244C54Q44349573-F5747095-6A66-47E0-801C-A6EF23B2A950Q44657793-0D7C10C5-0B82-4CD0-8C22-BDCB4C34E872Q46421625-631630AC-2443-4429-80E2-2D4895DC523FQ46722139-887BF879-A64A-4665-812E-4CAD578FD650Q46726322-DA3BB23A-889D-40FC-83EA-EB14054DF7E4Q51163942-57ACB2FE-0AF4-4948-9B44-2456C3059609
P2860
Buprenorphine prescription by general practitioners in a French region.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Buprenorphine prescription by general practitioners in a French region.
@en
Buprenorphine prescription by general practitioners in a French region.
@nl
type
label
Buprenorphine prescription by general practitioners in a French region.
@en
Buprenorphine prescription by general practitioners in a French region.
@nl
prefLabel
Buprenorphine prescription by general practitioners in a French region.
@en
Buprenorphine prescription by general practitioners in a French region.
@nl
P2093
P1476
Buprenorphine prescription by general practitioners in a French region
@en
P2093
J C Mabriez
J L Sanmarco
J Micallef
V Lapierre
P304
P356
10.1016/S0376-8716(01)00161-2
P50
P577
2002-01-01T00:00:00Z